These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Lai Z; Yang T; Kim YB; Sielecki TM; Diamond MA; Strack P; Rolfe M; Caligiuri M; Benfield PA; Auger KR; Copeland RA Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14734-9. PubMed ID: 12407176 [TBL] [Abstract][Full Text] [Related]
4. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Honda R; Yasuda H Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139 [TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-protein ligase activity of Hdm2 is inhibited by nucleic acids. Linares LK; Scheffner M FEBS Lett; 2003 Nov; 554(1-2):73-6. PubMed ID: 14596917 [TBL] [Abstract][Full Text] [Related]
6. Quantitative assays of Mdm2 ubiquitin ligase activity and other ubiquitin-utilizing enzymes for inhibitor discovery. Auger KR; Copeland RA; Lai Z Methods Enzymol; 2005; 399():701-17. PubMed ID: 16338390 [TBL] [Abstract][Full Text] [Related]
7. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203 [TBL] [Abstract][Full Text] [Related]
8. Overview of approaches for screening for ubiquitin ligase inhibitors. Sun Y Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387 [TBL] [Abstract][Full Text] [Related]
9. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Argentini M; Barboule N; Wasylyk B Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871 [TBL] [Abstract][Full Text] [Related]
17. Development of a ubiquitin transfer assay for high throughput screening by fluorescence resonance energy transfer. Boisclair MD; McClure C; Josiah S; Glass S; Bottomley S; Kamerkar S; Hemmilä I J Biomol Screen; 2000 Oct; 5(5):319-28. PubMed ID: 11080690 [TBL] [Abstract][Full Text] [Related]
18. High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor. Foote PK; Krist DT; Statsyuk AV Curr Protoc Chem Biol; 2017 Sep; 9(3):174-195. PubMed ID: 28910856 [TBL] [Abstract][Full Text] [Related]
19. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Boyd SD; Tsai KY; Jacks T Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695 [TBL] [Abstract][Full Text] [Related]
20. An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. Uldrijan S; Pannekoek WJ; Vousden KH EMBO J; 2007 Jan; 26(1):102-12. PubMed ID: 17159902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]